Literature DB >> 24012258

Retraction--Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study.

.   

Abstract

Entities:  

Year:  2013        PMID： 24012258     DOI： 10.1016/S0140-6736(13)61847-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Misconduct: Japan to learn from biomedical cases.

Authors:  Tetsuya Tanimoto; Masahiro Kami; Kenji Shibuya
Journal:  Nature       Date:  2014-08-28       Impact factor: 49.962

2.  A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of Medicine.

Authors:  Akihiko Ozaki; Morihito Takita; Tetsuya Tanimoto
Journal:  Invest New Drugs       Date:  2018-03-08       Impact factor: 3.850

Review 3.  A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan.

Authors:  Tetsuya Tanimoto
Journal:  Drug Des Devel Ther       Date:  2015-03-31       Impact factor: 4.162

Review 4.  Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?

Authors:  Flávio Danni Fuchs; James J DiNicolantonio
Journal:  Open Heart       Date:  2015-04-10

5.  Changes in Drug Utilization After Publication of Clinical Trials and Drug-Related Scandals in Japan: An Interrupted Time Series Analysis, 2005-2017.

Authors:  Shingo Fukuma; Tatsuyoshi Ikenoue; Yukari Yamada; Yoshiyuki Saito; Joseph Green; Takeo Nakayama; Shunichi Fukuhara
Journal:  J Epidemiol       Date:  2020-10-30       Impact factor: 3.211

6.  Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.

Authors:  Iekuni Ichikawa; Ellen Wright Clayton
Journal:  Account Res       Date:  2016       Impact factor: 2.622

7.  Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.

Authors:  Akihiko Ozaki; Hiroaki Saito; Yosuke Onoue; Toyoaki Sawano; Yuki Shimada; Yurie Somekawa; Aritsune Tsuji; Tetsuya Tanimoto
Journal:  BMJ Open       Date:  2019-09-06       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.